Debt-to-Equity Ratio

Beam Therapeutics' debt-to-equity ratio of 0.09x means the company uses very little debt relative to its shareholders' equity, indicating a low-leverage financial structure.

Compared to its healthcare sector peers, where the median ratio is 0.43x, Beam's ratio places it in the 31st percentile, showing it has less debt than most companies in its industry. The year-over-year change is not available, but the ratio dropped 59.1% quarter-over-quarter from 0.22x, reflecting a rapid reduction in debt or increase in equity. This combination of an already low ratio and a sharp quarterly decline suggests minimal financial risk from debt, but it may also indicate the company is relying more on equity financing or has paid down obligations quickly. For an investor, the low level and falling trend reduce default risk but could imply a conservative capital structure that limits potential leverage-driven growth. This metric supports the overall NEUTRAL verdict by confirming a stable, low-risk balance sheet without signaling either aggressive expansion or distress.

Frequently Asked Questions

Closest Sector Peers